ADMA Biologics Inc vs TeraWulf Inc — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while TeraWulf Inc trades at $18.05 (market cap $8.35B). The key difference: TeraWulf Inc is far larger — about 3.8× ADMA Biologics Inc's market cap, and TeraWulf Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | WULF | |
|---|---|---|
Market Cap | $2.22B | $8.35B |
Sector | Health | Technology |
52-Week High | $20.38 | $28.98 |
52-Week Low | $7.60 | $5.24 |
Enterprise Value | $2.29B | $10.97B |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →